Figure 2 Within the SOC level, gastrointestinal system disorders in overall GLP-1 RAs were overreported compared with the background frequency (ROR 1.46, PRR 1.33, IC 0.41, EBGM 1.33), which were further attributed to liraglutide (ROR 2.39, PRR 1.84, IC 0.88, EBGM 1.33), dulaglutide (ROR 1.39, PRR 1.28, IC 0.36, EBGM 1.25), and semaglutide (ROR 3.00, PRR 2.10, IC 1.07, EBGM 2.10), while exenatide (ROR 0.57, PRR 0.63, IC 0.68, EBGM 0.63) and lixisenatide (ROR 0.51, PRR 0.57, IC 0.81, EBGM 0.57) did not show the association with gastrointestinal AEs ( Table 2 )
Clinical data show that 4060% of users maintain most of their weight loss long-term when they combine supervised tapering, consistent exercise, high protein intake, and behavioral strategies
Wstpne wyniki na 30 pacjentach wykazay 42% popraw w skali bliznowania ECCA po trzech sesjach mikronakuwania poczonych z GHK-Cu + PRP, wobec 28% z samym PRP
Janumet Side Effects and Black Box Warning Because Janumet is a combination medication, it has the side effect risks of Januvia plus metformin